Skip to main content
Log in

Predictive factors for extended-spectrum beta-lactamase producing Enterobacteriaceae causing infection among intensive care unit patients with prior colonization

Infection Aims and scope Submit manuscript

Abstract

We investigated the predictive factors for extended-spectrum beta-lactamase producing Enterobacteriaceae (ESBL-PE) causing infections among intensive care unit patients with prior documented ESBL-PE colonization. Using multivariate analysis, referral from medical ward, nursing home or rehabilitation center [Odds ratio (OR), 2.5; 95 % confidence interval (CI), [1.3–5.0]; p = 0.007], previous fluoroquinolone treatment (OR, 3.4; CI, [1.1–10.5]; p = 0.003), extracorporeal membrane oxygenation (OR, 4.6; CI, [1.3–15.9]; p = 0.02), and absence of prior positive ESBL-PE rectal swab culture (OR, 5.0; CI, [1.6–10.0]; p = 0.0009) were risk factors for ESBL-PE infection. Easily identifiable factors may help with targeting carbapenem prescriptions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price includes VAT (France)

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Falagas ME, Karageorgopoulos DE. Extended-spectrum beta-lactamase-producing organisms. J Hosp Infect. 2009;73:345–54.

    Article  CAS  PubMed  Google Scholar 

  2. Schwaber MJ, Carmeli Y. Mortality and delay in effective therapy associated with extended-spectrum β-lactamase production in enterobacteriaceae bacteraemia: a systematic review and meta-analysis. J Antimicrob Chemother. 2007;60:913–20.

    Article  CAS  PubMed  Google Scholar 

  3. Razazi K, Derde LPG, Verachten M, Legrand P, Lesprit P, Brun-Buisson C. Clinical impact and risk factors for colonization with extended-spectrum β-lactamase-producing bacteria in the intensive care unit. Intensive Care Med. 2012;38:1769–78.

    Article  PubMed  Google Scholar 

  4. Armand-Lefèvre L, Angebault C, Barbier F, et al. Emergence of imipenem-resistant gram-negative bacilli in intestinal flora of intensive care patients. Antimicrob Agents Chemother. 2013;57:1488–95.

    Article  PubMed Central  PubMed  Google Scholar 

  5. Comité de l’antibiogramme de la société française de microbiologie 2011. http://www.sfm-microbiologie.org. Viewed in 19 March 2014.

  6. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control. 2008;36:309–32.

    Article  PubMed  Google Scholar 

  7. Carbonne A, Arnaud I, Maugat S, et al. National multidrug-resistant bacteria (MDRB) surveillance in France through the RAISIN network: a 9 year experience. J Antimicrob Chemother. 2013;68:954–9.

    Article  CAS  PubMed  Google Scholar 

  8. Réseau BMR-Raisin—resultats 2011. Surveillance des bactéries multirésistantes dans les établissements de santé en France. http://opac.invs.sante.fr/doc_num.php?explnum_id=8853. Viewed in 19 March 2014.

  9. Goulenok T, Ferroni A, Bille E, et al. Risk factors for developing ESBL E. coli: can clinicians predict infection in patients with prior colonization? J Hosp Infect. 2013;84:294–9.

    Article  CAS  PubMed  Google Scholar 

  10. Sullivan A, Edlund C, Nord CE. Effect of antimicrobial agents on the ecological balance of human microflora. Lancet Infect Dis. 2001;1:101–14.

    Article  CAS  PubMed  Google Scholar 

  11. Paterson DL, Mulazimoglu L, Casellas JM, et al. Epidemiology of ciprofloxacin resistance and its relationship to extended-spectrum beta-lactamase production in Klebsiella pneumoniae isolates causing bacteremia. Clin Infect Dis. 2000;30:473–8.

    Article  CAS  PubMed  Google Scholar 

  12. Réglier-Poupet H, Naas T, Carrer A, et al. Performance of chromID ESBL, a chromogenic medium for detection of enterobacteriaceae producing extended-spectrum beta-lactamases. J Med Microbiol. 2008;57:310–5.

    Article  PubMed  Google Scholar 

  13. Rodríguez-Baño J, Navarro MD, Retamar P, Picón E, Pascual Á. β-Lactam/β-lactam inhibitor combinations for the treatment of bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli: a post hoc analysis of prospective cohorts. Clin Infect Dis. 2012;54:167–74.

    Article  PubMed  Google Scholar 

  14. Curtis LT. Prevention of hospital-acquired infections: review of non-pharmacological interventions. J Hosp Infect. 2008;64:204–19.

    Article  Google Scholar 

Download references

Acknowledgments

The authors would like to thank Mrs. Alison Good (Scotland, UK) for her helpful review of the manuscript.

Conflict of interest

All authors declare that there is no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to B. Mégarbane.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vodovar, D., Marcadé, G., Rousseau, H. et al. Predictive factors for extended-spectrum beta-lactamase producing Enterobacteriaceae causing infection among intensive care unit patients with prior colonization. Infection 42, 743–748 (2014). https://doi.org/10.1007/s15010-014-0619-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15010-014-0619-z

Keywords

Navigation